592 — Lexington, Kentucky

592 is a clinical research site located in Lexington, Kentucky, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

592 has participated in 1 clinical trials.

Therapeutic areas: Systemic Lupus Erythematosus.

Sponsors: UCB Pharma.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Lexington

Browse all research sites in Kentucky · View every site in Lexington

• University of Kentucky Univ Kebtucky
• University of Kentucky Cystic Fibrosis Clinic
• University of Kentucky-Markey Cancer Center Clinical Research Organization
• University of Kentucky Department of Otolaryngology
• University of Kentucky Hospital Epilepsy Monitoring Unit
• University of Kentucky, Department of Ophthamology
• Saint Joseph Hospital East
• University of Kentucky College of Medicine UK Medical Center
• University of KY- Markey Cancer Center
• University of Kentucky General Pediatrics Clinic
• University of Kentucky Chandler Medical Center /ID# 155423
• Lexington VA Medical Center - Cooper Division ( Site 0137)

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 592?

592 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 592 conducted?

592 has 1 clinical trials on record. Their work covers Systemic Lupus Erythematosus.

Is 592 accredited by Crixeo Clinical Trials?

592 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 592?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.